Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

August 15, 2020; Volume 17,Issue 3

Editorial

  • You have access
    Challenges and recommendations for cancer care in the COVID-19 pandemic
    Jianbo Tian and Xiaoping Miao
    Cancer Biology & Medicine August 2020, 17 (3) 515-518; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0300

Review

  • You have access
    COVID-19 in cancer patients: risk, clinical features, and management
    Cuiwei Liu, Yanxia Zhao, Derick Okwan-Duodu, Reva Basho and Xiaojiang Cui
    Cancer Biology & Medicine August 2020, 17 (3) 519-527; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0289
  • You have access
    CMTM family proteins 1–8: roles in cancer biological processes and potential clinical value
    Jie Wu, Lan Li, Siyi Wu and Bin Xu
    Cancer Biology & Medicine August 2020, 17 (3) 528-542; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0032
  • You have access
    Active surveillance as a management strategy for papillary thyroid microcarcinoma
    Huan Zhang, Xiangqian Zheng, Juntian Liu, Ming Gao and Biyun Qian
    Cancer Biology & Medicine August 2020, 17 (3) 543-554; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0470
  • You have access
    Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
    Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu
    Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
  • You have access
    MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
    Zhe Cao, Jiangdong Qiu, Gang Yang, Yueze Liu, Wenhao Luo, Lei You, Lianfang Zheng and Taiping Zhang
    Cancer Biology & Medicine August 2020, 17 (3) 569-582; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0033
  • You have access
    Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets
    Yungang Wang, Shouyan Deng and Jie Xu
    Cancer Biology & Medicine August 2020, 17 (3) 583-598; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0066
  • You have access
    The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai, Jian Zhang, Yaru Tian, Ji Li, Wang Jing, Hongbo Guo and Hui Zhu
    Cancer Biology & Medicine August 2020, 17 (3) 599-611; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0102
  • You have access
    Zinc dysregulation in cancers and its potential as a therapeutic target
    Jie Wang, Huanhuan Zhao, Zhelong Xu and Xinxin Cheng
    Cancer Biology & Medicine August 2020, 17 (3) 612-625; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0106
  • You have access
    Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors
    Min Liu, Qian Sun, Feng Wei and Xiubao Ren
    Cancer Biology & Medicine August 2020, 17 (3) 626-639; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0112

Original Article

  • You have access
    Kinetochore protein MAD1 participates in the DNA damage response through ataxia-telangiectasia mutated kinase-mediated phosphorylation and enhanced interaction with KU80
    Mingming Xiao, Xuesong Li, Yang Su, Zhuang Liu, Yamei Han, Shuai Wang, Qinghua Zeng, Hong Liu, Jianwei Hao and Bo Xu
    Cancer Biology & Medicine August 2020, 17 (3) 640-651; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0044
  • You have access
    Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer
    Keson Trakunram, Pichitpon Chaniad, Sarayut Lucien Geater, Warangkana Keeratichananont, Voravit Chittithavorn, Sumonmal Uttayamakul, Suhaimee Buya, Pritsana Raungrut and Paramee Thongsuksai
    Cancer Biology & Medicine August 2020, 17 (3) 652-663; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0063
  • You have access
    TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma
    Yingbin Xie, Luyue Chen, Junhu Zhou, Chao Yang, Can Xu, Xiangyu Fan, Yanli Tan, Yanan Wang, Chunsheng Kang and Chuan Fang
    Cancer Biology & Medicine August 2020, 17 (3) 664-675; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0356
  • You have access
    An ATF24 peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment
    Bingtao Zhai, Peng Chen, Wengang Wang, Shuiping Liu, Jiao Feng, Ting Duan, Yu Xiang, Ruonan Zhang, Mingming Zhang, Xuemeng Han, Xiaying Chen, Qiujie Li, Guohua Li, Ying Liu, Xingxing Huang, Wenzheng Zhang, Ting Pan, Lili Yan, Ting Jin, Tian Xie and Xinbing Sui
    Cancer Biology & Medicine August 2020, 17 (3) 676-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0454
  • You have access
    An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway
    Xiaotong Zhang, Gengyi Zou, Xiyang Li, Lun Wang, Tianyu Xie, Jin Zhao, Longlong Wang, Shunchang Jiao, Rong Xiang, Haoyu Ye and Yi Shi
    Cancer Biology & Medicine August 2020, 17 (3) 693-706; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0010
  • You have access
    SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability via the PI3K/AKT/GSK3β signaling pathway
    Yue Yuan, Yanling Fan, Zicong Gao, Xuan Sun, He Zhang, Zhiyong Wang, Yanfen Cui, Weijie Song, Zhaosong Wang, Fei Zhang and Ruifang Niu
    Cancer Biology & Medicine August 2020, 17 (3) 707-725; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0056
  • You have access
    Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma
    Liang Wang, Steven Mo, Xin Li, Yingzhi He and Jing Yang
    Cancer Biology & Medicine August 2020, 17 (3) 726-739; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0073
  • You have access
    Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiation via downregulating frizzled class receptor 10
    Jiongyu Chen, Fan Zhang, Xiaosha Ren, Yahui Wang, Wenhe Huang, Jianting Zhang and Yukun Cui
    Cancer Biology & Medicine August 2020, 17 (3) 740-752; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0219
  • You have access
    Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling
    Tingting Qin, Zhujun Liu, Jing Wang, Junling Xia, Shaochuan Liu, Yanan Jia, Hailin Liu and Kai Li
    Cancer Biology & Medicine August 2020, 17 (3) 753-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0024
  • You have access
    Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer
    Runsen Jin, Chengming Liu, Sufei Zheng, Xinfeng Wang, Xiaoli Feng, Hecheng Li, Nan Sun and Jie He
    Cancer Biology & Medicine August 2020, 17 (3) 768-781; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0121
  • You have access
    Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library
    Yuanzhong Wu, Liwen Zhou, Zifeng Wang, Xin Wang, Ruhua Zhang, Lisi Zheng and Tiebang Kang
    Cancer Biology & Medicine August 2020, 17 (3) 782-794; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0162
  • You have access
    Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study
    Liqiang Wei, Lei Yang, Jin Ye, Jia Cong, Xin Li, Na Yao, Jing Yang, Xueying Cui, Jing Ding, Yiping Wu and Jingwen Wang
    Cancer Biology & Medicine August 2020, 17 (3) 795-804; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0160
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 17 (3)
Cancer Biology & Medicine
Vol. 17, Issue 3
15 Aug 2020
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire